PPD-backed siteless trial specialist Medable reels in $78M as the pandemic continues to push its biz forward

Decentralized study company Medable has raised $78 million in its third funding round less than six months after grabbing $91 million.

The Californian company, one of a group of digital trial specialists cashing in on the siteless study craze amid the pandemic, saw its latest round led by Sapphire Ventures along with new investor Obvious Ventures and follow-on investment from existing investors GSR Ventures, PPD and Streamlined Ventures.